Abramenko, N.; Vellieux, F.; Tesařová, P.; Kejík, Z.; Kaplánek, R.; Lacina, L.; Dvořánková, B.; Rösel, D.; Brábek, J.; Tesař, A.;
et al. Estrogen Receptor Modulators in Viral Infections Such as SARS−CoV−2: Therapeutic Consequences. Int. J. Mol. Sci. 2021, 22, 6551.
https://doi.org/10.3390/ijms22126551
AMA Style
Abramenko N, Vellieux F, Tesařová P, Kejík Z, Kaplánek R, Lacina L, Dvořánková B, Rösel D, Brábek J, Tesař A,
et al. Estrogen Receptor Modulators in Viral Infections Such as SARS−CoV−2: Therapeutic Consequences. International Journal of Molecular Sciences. 2021; 22(12):6551.
https://doi.org/10.3390/ijms22126551
Chicago/Turabian Style
Abramenko, Nikita, Fréderic Vellieux, Petra Tesařová, Zdeněk Kejík, Robert Kaplánek, Lukáš Lacina, Barbora Dvořánková, Daniel Rösel, Jan Brábek, Adam Tesař,
and et al. 2021. "Estrogen Receptor Modulators in Viral Infections Such as SARS−CoV−2: Therapeutic Consequences" International Journal of Molecular Sciences 22, no. 12: 6551.
https://doi.org/10.3390/ijms22126551
APA Style
Abramenko, N., Vellieux, F., Tesařová, P., Kejík, Z., Kaplánek, R., Lacina, L., Dvořánková, B., Rösel, D., Brábek, J., Tesař, A., Jakubek, M., & Smetana, K., Jr.
(2021). Estrogen Receptor Modulators in Viral Infections Such as SARS−CoV−2: Therapeutic Consequences. International Journal of Molecular Sciences, 22(12), 6551.
https://doi.org/10.3390/ijms22126551